Basics ARS Pharmaceuticals, Inc. IPO Date: December 4, 2020 Sector: Healthcare Industry: Biotech Market Cap: $1.72B Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 2.90% Avg Daily Range (30 D): $0.44 | 2.66% Avg Daily Range (90 D): $0.42 | 2.96% Institutional Daily Volume Avg Daily Volume: .86M Avg Daily Volume (30 D): 1.19M Avg Daily Volume (90 D): 1.41M Trade Size Avg Trade Size (Sh.): 90 Avg Trade Size (Sh.) (30 D): 72 Avg Trade Size (Sh.) (90 D): 76 Institutional Trades Total Inst.Trades: 535 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $2.33M Avg Inst. Trade (90 D): $2.22M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.75M Avg Closing Trade (30 D): $2.97M Avg Closing Trade (90 D): $2.42M Avg Closing Volume: 148.64K     News Jan 6, 2025 @ 1:00 PM ARS Pharmaceuticals Files for Approval of neffyÂÂ... Source: N/A Dec 13, 2024 @ 9:58 PM ARSファーマシューã... Source: N/A Dec 13, 2024 @ 9:58 PM ARS Pharmaceuticals 宣布在中å›Â... Source: Ars Pharmaceuticals, Inc. Dec 12, 2024 @ 7:32 PM ARS Pharmaceuticals Announces Filings for Approval... Source: Ars Pharmaceuticals, Inc. Nov 6, 2024 @ 3:00 PM The Physician-Patient Alliance for Health & Safety... Source: Globe Newswire Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.17 $-.35 $.51 Diluted EPS $-.17 $-.35 $.51 Revenue $ 97.12M $ 7.97M $ 86.58M Gross Profit $ $ $ Net Income / Loss $ -15.65M $ -33.94M $ 49.93M Operating Income / Loss $ -27.07M $ -37.18M $ 47.2M Cost of Revenue $ $ $ Net Cash Flow $ -16.14M $ -10.95M $ 11.16M PE Ratio